Z3 Capital Partners’s Astera Labs ALAB Stock Holding History

Z3 Capital Partners’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.84M	Sell	20,370 -100	-0.5%	-$26.5K	2.07%	13
2026 Q1	$2.24M	Buy	20,470 +3,300	+19%	+$470K	0.57%	43
2025 Q4	$2.86M	Buy	+17,170	New	+$2.87M	0.69%	37

Other funds holding ALAB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Z3 Capital Partners's ALAB Position: Q2 2026 in Review

Z3 Capital Partners reduced its Astera Labs (ALAB) stake by 0.49% in Q2 2026, selling an estimated $26.5K and leaving 20,370 shares worth $9.84M. The position accounts for 2.07% of the portfolio, ranked #13.

Z3 Capital Partners first reported a position in ALAB in Q4 2025 and has held it in 3 quarters since. 918 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Z3 Capital Partners held 20,370 shares of Astera Labs worth $9.84M as of Q2 2026.
Z3 Capital Partners sold 100 Astera Labs shares in Q2 2026, an estimated $26.5K.
Astera Labs made up 2.07% of Z3 Capital Partners's portfolio in Q2 2026, its #13 holding.
Z3 Capital Partners first reported a position in Astera Labs in Q4 2025 and has held it in 3 quarters since.
918 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Z3 Capital Partners's 13F filing for Q2 2026, filed 28 Jul 2026.